Skip to content

AOA Dx vs Exai Bio

AOA Dx logo

AOA Dx

Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI

56 employees · est. 2020 · Denver, United States

VS
Exai Bio logo

Exai Bio

Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cancer diagnosis

22 employees · est. 2021 · Palo Alto, United States

AOA Dx is the older company (2020 vs 2021); AOA Dx is the larger of the two.

Side-by-Side Comparison

AOA Dx Exai Bio
Founded
2020 older 2021
Headquarters
Denver, United States Palo Alto, United States
Employees
56 larger 22
Industry
Biotechnology, Health Care Biotechnology, Health Care
Total Funding
$29.00M $138.96M
Funding Rounds
6 2
Services
AI-enabled early cancer detection, Development of cancer biomarkers, Innovative diagnostic platforms Cancer detection through next-generation RNA-based platform, Integration of novel RNA biomarkers with AI for clinical insights, Development and application of oncRNA technology
Target Customers
Healthcare providers, Medical researchers, Women at risk of ovarian cancer, Health-conscious individuals Healthcare professionals, Medical researchers, Cancer treatment centers, Diagnostic laboratories, Biotech investors
Taxonomy
Early-Stage Cancer DetectionAI In HealthcareBiomarker TechnologyLiquid BiopsyOvarian Cancer DiagnosticsWomen’s Health +6 Liquid BiopsyCancer DetectionCancer DiagnosisPersonalized MedicineRNA BiologyClinical Insights +6
Website
aoadx.com exai.bio
AOA Dx logo

About AOA Dx

AOA Dx is at the forefront of innovation in the realm of early-stage cancer detection, setting new precedents in Biotechnology and Health Care. Established in 2020, the company is based in the United States and is committed to transforming women’s health via breakthrough diagnostics. The core of AO...

Exai Bio logo

About Exai Bio

Exai Bio, founded in 2021, is pioneering a next-generation liquid biopsy platform to support early detection and precise diagnosis of cancer, aligning with its mission to innovatively target cancer treatment. By leveraging proprietary RNA and artificial intelligence technology, the company promises...

Also comparing in this category

Comparing more than these two?

Get AOA Dx, Exai Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does AOA Dx compare?

A PDF of AOA Dx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

AOA Dx was founded in 2020, based in Denver, United States, with 56 employees. AOA Dx is at the forefront of innovation in the realm of early-stage cancer detection, setting new precedents in Biotechnology and Health Care. Established in 2020, the company is based in the United. Exai Bio was founded in 2021, based in Palo Alto, United States, with 22 employees. Exai Bio, founded in 2021, is pioneering a next-generation liquid biopsy platform to support early detection and precise diagnosis of cancer, aligning with its mission to innovatively target cancer tr.
AOA Dx has raised $29.00M and Exai Bio $138.96M.
Both work in Biotechnology and Health Care and list ai in healthcare and liquid biopsy among their focus areas.

Compare AOA Dx with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AOA Dx on 10 Apr 2026, and Exai Bio on 12 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout